NAGE FY 2018 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$393M

FY 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$32M+48.8% YoY

Gross Profit

$16M50.9% margin

Operating Income

-$33M-105.1% margin

Net Income

-$33M-105.6% margin

EPS (Diluted)

$-0.61

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$22M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$42M

Total Liabilities

$15M

Stockholders' Equity

$27M

Cash & Equivalents

$22M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$32M	$21M	+48.8%
Gross Profit	$16M	$10M	+53.2%
Operating Income	-$33M	-$16M	-102.6%
Net Income	-$33M	-$11M	-192.8%